U.S. federal trademark · Serial No. 90531584
Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; drug delivery agents consisting of a biological compound in the form of a molecular complex that acts as a platform that facilitates delivery of ribonucleic acid RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies; oligonucleotide compounds for use in the targeted delivery of RNA interference (RNAi) therapy; oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes
Research and development of pharmaceutical products; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections
Custom manufacture of oligonucleotides
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.